News

The Biomedical Diagnostics Institute (BDI) based at Dublin City University (DCU) announced that it has invested in Biacore™ A100 label-free protein interaction analysis system.

Ipsogen SA, a molecular diagnostic company specialized in the development, manufacturing and commercialization of diagnostic assays for breast cancer and leukemia, today announced a non-exclusive license agreement with Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, for the use of the JAK2 V617F mutation in Quest Diagnostic's laboratory developed tests.

deCODE genetics announced that on September 30, 2008 it received a notice from the Nasdaq Stock Market stating that for 10 consecutive trading days the market value of deCODE’s common stock had been below $50 million, the minimum level required for continued listing on The Nasdaq Global Market as set forth in Nasdaq Marketplace Rule 4450(b)(1)(A).

Company initiated first multiple dose trial of inflammatory bowel disease drug candidate.

The collaboration will apply Deciphera's phylomechanics platform with Lilly's expertise to study B-Raf kinase inhibitors for cancer treatments.

The agreement is aimed at the development of electrophysiologically optimized ion channel cell lines which allow a reliable testing of substances and drugs.

Aptuit INDiGO™ accelerates drug development from pre-clinical candidate selection to regulatory filing on a fixed timeline.

From asthma and cancer treatments to vaccines, research in children saves lives and improves their health and well-being. A new Web site from the National Institutes of Health (NIH), "Children and Clinical Studies", offers parents and health care providers an insider's guide to children's medical research.

About 20 percent of isolated cleft lip, one of the world's most common birth defects, may be due to a one-letter difference in the DNA sequence of a gene involved in facial development, researchers supported by the National Institutes of Health report.

The companies have received a €7.9 million grant to support Tracker, a theranostics project concerning rheumatoid arthritis.